The implementation of a commercially available multi-gene profile test for breast cancer characterization in a department of pathology: what have we learned from the first 100 cases?-Reference-Cited by-同舟云学术

The implementation of a commercially available multi-gene profile test for breast cancer characterization in a department of pathology: what have we learned from the first 100 cases?

Published:2021-01-06 Issue:6 Volume:478 Page:1079-1087
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Pelliccia Cristina,Caselli Emanuele,Mandarano Martina^ORCID,Del Sordo Rachele,Bellezza Guido,Sidoni Angelo

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00428-020-02994-3.pdf

Reference28 articles.

1. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS, Hayes M, Hicks DG, Lester S, Love R, Mangu PB, McShane L, Miller K, Osborne CK, Paik S, Perlmutter J, Rhodes A, Sasano H, Schwartz JN, Sweep FC, Taube S, Torlakovic EE, Valenstein P, Viale G, Visscher D, Wheeler T, Williams RB, Wittliff JL, Wolff AC, American Society of Clinical Oncology, College of American Pathologists (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 134(7):e48–e72. https://doi.org/10.1043/1543-2165-134.7.e48

2. Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A, McShane LM, Paik S, Pegram MD, Perez EA, Press MF, Rhodes A, Sturgeon C, Taube SE, Tubbs R, Vance GH, van de Vijver M, Wheeler TM, Hayes DF (2007) American Society of Clinical O, and College of American P American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25(1):118–145. https://doi.org/10.1200/JCO.2006.09.2775

3. Khoury T (2018) Delay to formalin fixation (cold ischemia time) effect on breast cancer molecules. Am J Clin Pathol 149(4):275–292. https://doi.org/10.1093/ajcp/aqx164

4. Denkert C, Budczies J, von Minckwitz G, Wienert S, Loibl S, Klauschen F (2015) Strategies for developing Ki67 as a useful biomarker in breast cancer. Breast 24(Suppl 2):S67–S72. https://doi.org/10.1016/j.breast.2015.07.017

5. Rakha EA, Starczynski J, Lee AH, Ellis IO (2014) The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice. Histopathology 64(5):609–615. https://doi.org/10.1111/his.12357

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Firmas génicas en el cáncer de mama;Revista de Senología y Patología Mamaria;2022-07

2. Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict);Breast Cancer Research and Treatment;2021-11-16

3. Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach;Cancers;2021-07-24